Contemporary Clinical Dentistry
   
  Home | About us | Editorial board | Search
Ahead of print | Current Issue | Archives | Advertise
Instructions | Online submission| Contact us | Subscribe |

 

Login  | Users Online: 497  Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size 

ORIGINAL ARTICLE
Year : 2013  |  Volume : 4  |  Issue : 3  |  Page : 303-306

Estimation of prostaglandin E 2 levels in gingival crevicular fluid in periodontal health, disease and after treatment


1 Department of Periodontics and Implantology, CKS Teja Institute of Dental Sciences and Research, Tirupati, India
2 Department of Periodontics, Rajiv Gandhi Institute of Medical Sciences, Kadapa, India
3 Department of Periodontics, St. Josephs Dental College, Eluru, India
4 Department of Periodontics, Meghana Institute of Dental Sciences and Research, Nizamabad, Andhra Pradesh, India

Correspondence Address:
N Ravindra Reddy
Department of Periodontics and Implantology, CKS Teja Institute of Dental Sciences and Research, Tirupati - 517 506, Andhra Pradesh
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0976-237X.118354

Rights and Permissions

Background and Objectives: Initial research has shown a positive correlation between the severity of periodontal disease (PD) and prostaglandin E 2 (PGE 2 ) concentrations in gingival crevicular fluid (GCF). However, there are no enough reports to correlate the PGE 2 concentrations in GCF in periodontal health, disease and after treatment. Hence, the present study is aimed to estimate the levels of PGE 2 in GCF in periodontal health, disease and after periodontal therapy. Materials and Methods: A periodontal examination and collection of GCF by extracrevicular method was performed in 25 subjects selected randomly and categorized into three groups on the basis of plaque index, gingival index, probing pocket depth and clinical attachment level. Group I (healthy) consists of 10 subjects, Group II (chronic periodontitis) consists of 15 patients and Group III (after treatment group) consists of 15 patients of Group II. PGE 2 levels were estimated in GCF samples by using the enzyme linked immunosorbent assay. Results: All clinical parameters improved significantly after therapy (P < 0.001). PGE 2 was detected in all the samples. Highest mean PGE 2 concentrations in GCF were obtained for Group II while the lowest concentrations were seen in Group I and Group III. Statistically significant difference was found between the levels of PGE 2 at Group-II and Group-III (P < 0.05). Conclusion: There is a substantial increase in the concentrations of PGE 2 as PD progresses. Since PGE 2 levels in GCF are positively correlated with gingival index, plaque index, probing pocket depths and clinical attachment levels, PGE 2 may be considered as a "Novel Biomarker" in PD progression. However, controlled, longitudinal studies are needed to confirm this possibility.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2107    
    Printed37    
    Emailed0    
    PDF Downloaded232    
    Comments [Add]    
    Cited by others 7    

Recommend this journal